Free Trial

Tenax Therapeutics (TENX) Competitors

Tenax Therapeutics logo
$5.81 +0.03 (+0.52%)
As of 03:54 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

TENX vs. HURA, IOBT, WHWK, OCX, VIRI, CRBP, ADAG, ENTX, ORMP, and JMAC

Should you be buying Tenax Therapeutics stock or one of its competitors? The main competitors of Tenax Therapeutics include TuHURA Biosciences (HURA), IO Biotech (IOBT), Whitehawk Therapeutics (WHWK), OncoCyte (OCX), Virios Therapeutics (VIRI), Corbus Pharmaceuticals (CRBP), Adagene (ADAG), Entera Bio (ENTX), Oramed Pharmaceuticals (ORMP), and Maxpro Capital Acquisition (JMAC). These companies are all part of the "pharmaceutical products" industry.

Tenax Therapeutics vs. Its Competitors

Tenax Therapeutics (NASDAQ:TENX) and TuHURA Biosciences (NASDAQ:HURA) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, institutional ownership, media sentiment, earnings, profitability and dividends.

In the previous week, TuHURA Biosciences had 3 more articles in the media than Tenax Therapeutics. MarketBeat recorded 3 mentions for TuHURA Biosciences and 0 mentions for Tenax Therapeutics. Tenax Therapeutics' average media sentiment score of 0.00 beat TuHURA Biosciences' score of -0.53 indicating that Tenax Therapeutics is being referred to more favorably in the media.

Company Overall Sentiment
Tenax Therapeutics Neutral
TuHURA Biosciences Negative

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tenax TherapeuticsN/AN/A-$17.60M-$2.48-2.34
TuHURA BiosciencesN/AN/A-$21.68MN/AN/A

TuHURA Biosciences' return on equity of 291.69% beat Tenax Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Tenax TherapeuticsN/A -31.51% -30.35%
TuHURA Biosciences N/A 291.69%122.09%

Tenax Therapeutics has a beta of 1.61, suggesting that its stock price is 61% more volatile than the S&P 500. Comparatively, TuHURA Biosciences has a beta of 0.17, suggesting that its stock price is 83% less volatile than the S&P 500.

1.7% of Tenax Therapeutics shares are held by institutional investors. Comparatively, 0.6% of TuHURA Biosciences shares are held by institutional investors. 3.1% of Tenax Therapeutics shares are held by insiders. Comparatively, 0.2% of TuHURA Biosciences shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Tenax Therapeutics currently has a consensus price target of $17.50, suggesting a potential upside of 201.20%. TuHURA Biosciences has a consensus price target of $12.67, suggesting a potential upside of 405.66%. Given TuHURA Biosciences' stronger consensus rating and higher possible upside, analysts clearly believe TuHURA Biosciences is more favorable than Tenax Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tenax Therapeutics
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
3.25
TuHURA Biosciences
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
2 Strong Buy rating(s)
3.40

Summary

TuHURA Biosciences beats Tenax Therapeutics on 6 of the 11 factors compared between the two stocks.

Get Tenax Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for TENX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TENX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TENX vs. The Competition

MetricTenax TherapeuticsMED IndustryMedical SectorNASDAQ Exchange
Market Cap$24.11M$2.97B$5.58B$9.03B
Dividend YieldN/A2.44%5.25%4.03%
P/E Ratio-2.3421.0427.1820.17
Price / SalesN/A258.76415.50184.26
Price / CashN/A41.8337.0657.97
Price / Book0.227.758.085.60
Net Income-$17.60M-$54.96M$3.16B$248.50M
7 Day Performance-2.52%5.66%3.64%5.07%
1 Month Performance0.52%4.10%3.78%7.53%
1 Year Performance74.47%6.20%34.08%21.54%

Tenax Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TENX
Tenax Therapeutics
1.2779 of 5 stars
$5.81
+0.5%
$17.50
+201.2%
+85.4%$24.11MN/A-2.349
HURA
TuHURA Biosciences
1.2307 of 5 stars
$2.23
+0.5%
$12.67
+468.0%
N/A$96.97MN/A0.00N/A
IOBT
IO Biotech
3.4401 of 5 stars
$1.39
-3.5%
$9.33
+571.5%
+22.0%$94.87MN/A-0.9330News Coverage
Positive News
WHWK
Whitehawk Therapeutics
N/A$1.87
-3.1%
N/AN/A$90.92M$25.98M0.0040
OCX
OncoCyte
2.0239 of 5 stars
$3.18
+16.3%
$6.06
+90.9%
+6.2%$90.80M$3.84M-0.90120
VIRI
Virios Therapeutics
N/A$4.71
-1.3%
$5.00
+6.2%
+1,754.4%$90.71MN/A-17.445
CRBP
Corbus Pharmaceuticals
3.835 of 5 stars
$6.90
-6.8%
$50.88
+637.3%
-83.6%$90.55MN/A-1.6440
ADAG
Adagene
2.0171 of 5 stars
$1.95
+1.6%
$8.00
+310.3%
-31.6%$90.45M$100K0.00260Gap Up
ENTX
Entera Bio
2.2525 of 5 stars
$1.90
-4.0%
$10.00
+426.3%
+1.7%$89.99M$180K-7.3120Positive News
Gap Down
ORMP
Oramed Pharmaceuticals
N/A$2.25
+4.7%
N/A-13.2%$87.83M$1.34M-5.1110
JMAC
Maxpro Capital Acquisition
N/A$6.51
+1.5%
N/A+3,271.7%$87.42MN/A0.002,021

Related Companies and Tools


This page (NASDAQ:TENX) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners